BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Policy

  FDA Clears St. Jude Medical’s Texas Neuromodulation Plant

  August 27, 2014

   · 

  2 min read
• Lone Star Bio

  AirStrip Technologies, Inc. Grabs $25 Million; Aims For New Territory

  August 27, 2014

   · 

  5 min read
• Business

  Fresh From Co-Founding Massively Financed Juno Therapeutics, Arch Venture Partners Banks $400 Million+ To Back New Biotechs

  August 27, 2014

   · 

  3 min read
• Deals

  Medtronic, Inc. Spends Another $350 Million On NGC Medical SpA

  August 27, 2014

   · 

  4 min read
• BioMidwest

  Medtech Startup, Sisu Global Health, Wins Grant To Make Medical Devices For Developing World

  August 27, 2014

   · 

  1 min read
• Drug Development

  Innate Pharma : Orphan Drug Designation In The European Union For Iph4102

  August 27, 2014

   · 

  4 min read
• Pharm Country

  Together With Direct Relief And The National Association Of Community Health Centers - Announce Winners Of The 2014 Becton, Dickinson and Company Helping Build Healthy Communities(SM) Innovations In Care Awards

  August 27, 2014

   · 

  5 min read
• BioCapital

  Clongen Laboratories, LLC Expands Tick And Arthropod-Borne Illness Testing By Offering New Diagnostic Assays For Emerging Pathogens

  August 27, 2014

   · 

  3 min read
• Drug Development

  Cannabis Science Inc. Provides Updated Guidance On Its Current Pre-Clinical Drug Development Programs Beginning With The Scientific Cannabis Cultivation Programs In Europe And North America, Testing Multiple Cannabis Strains For Multiple Critical Ailments

  August 27, 2014

   · 

  2 min read
• Drug Development

  RedHill Biopharma Ltd. Provides Update On Expansion Of Ongoing RHB-105 Phase 3 Study, Targeting Broadened H. Pylori Indication Authorized By FDA

  August 27, 2014

   · 

  10 min read